Arifon ghara

"Arifon ghara" nwere mamịrị, hypotensive edinam.

The nkwadebe gụnyere indapamide (ifịk umi), na inyeaka Efrata: lactose monohydrate, magnesium stearate, hypromellose, anhydrous colloidal silica, povidone.

Mbadamba "Arifon ghara" biconvex ntekwasa ọcha film mkpuchi.

The n'ọrụ mgwa nke ọgwụ na-nchọ na a pụrụ iche ụgbọelu matriks, na-enye a edo achịkwa ntọhapụ nke ya na eriri afọ tract.

Indapamide a gụnyere ke otu nke sulfonamide nkwekọrịta, ya pharmacological Njirimara yiri ndị nke thiazide diuretics, inhibiting na reabsorption nke sodium ion na akaghị nke cortical nephrons.

"Arifon ghara" gosiri maka ọbara mgbali.

Ọ bụghị kenyere agwọ ọrịa mmadụ hypersensitive na-arụsi ọrụ ike umi, ọzọ sulfonamide nkwekọrịta ma ọ bụ ọ bụla akụrụngwa nke inyeaka agwọ ọrịa. Contraindicated "Arifon ghara" na akụrụ odida na oké ụdị nke hepatic encephalopathy ma ọ bụ oké njọ imebi nke hepatic ọrụ, nakwa dị ka hypokalemia.

The ọgwụ na-adịghị atụ aro ka a họpụta mmadụ na-ata ahụhụ site na lactose ekweghị ibe nọrọ, malabsorption (glucose-galactose), galactosemia.

Ihe ókè ịkpachara anya, "ghara Arifon" ga-eji maka ọrịa nke imeju na-na akụrụ ọrụ, ọmụmụ na electrolyte itule, adịghị ike na ọrịa ma ọ bụ ná nhọpụta nke ọrịa na concomitant ọgwụ na antiarrhythmic ọgwụ ọjọọ, nakwa dị ka ọrịa shuga, hyperparathyroidism.

Unu na-eji ọgwụ maka ụmụaka n'okpuru iri na asatọ afọ ruru ka a enweghị adakarị data n'ọtụtụ zuru ezu.

N'oge ime, dị ka a na-achị, na-ekwesịghị kenyere diuretics. Unu na-eji ndị a ọgwụ ọjọọ eme ihe na ọgwụgwọ nke n'ahụ edema na prenatal oge. Ọ ga-kwuru na mamịrị ọgwụ ọjọọ nwere ike kpasuo fetoplacental ischemia na-eduga na-enwe nsogbu na nwa ebu n'afọ na mmepe.

N'ihi indapamide nwere ikike na-eguzo na-ara-ehi, na-atụ aro "Arifon" lactation.

Dị ka adakarị na laabu kwa, ọtụtụ oghom ihe nwere a dose-dabere n'ụzọ.

Ahụkarị oghom mmetụta na-:

• paraesthesia, dizziness, ike ọgwụgwụ, isi ọwụwa;
• anaemia (aplastic, hemolytic), leukopenia, thrombocytopenia, agranulocytosis;
• ẹsụhọde ọbara mgbali, arrhythmia;
• ọgbụgbọ, pancreatitis, akọrọ ọnụ, vomiting, afọ ntachi;
• gbasara akụrụ odida;
• disturbances nke imeju ọrụ;
• amụba uche nke anụ ahụ, na-emekarị na susceptible asthmatic na anabata ọnọdụ, maculopapular ọkụ ọkụ, hemorrhagic vasculitis, angioedema, urticaria.

Ọgwụ e ji ọnụ na, na ụfọdụ mmiri mmiri, na-enweghị ịta. Daily dose - otu mbadamba. Ọ na-atụ aro na-ụtụtụ.

Na ọgwụgwọ nke ọbara mgbali dịkwuo onunu ogwu anaghị dịkwuo antihypertensive mmetụta, ma nwekwara ike dịkwuo mamịrị mmetụta.

N'ịhọpụta ọgwụ agadi ọrịa mkpa igosipụta achịkwa creatinine larịị dị na ha ibu, afọ na okike. Na nkịtị ma ọ bụ ubé disordered gbasara akụrụ ọrụ ndị ọrịa na ihe nká kwere ọgwụ ọgwụ na a dose nke otu mbadamba na awa 24.

Dị nnọọ elu doses nke indapamide (ruo iri anọ milligrams) nwere dịghị nsí mmetụta.

Chọpụtabeghị imebi nke psychomotor Jeremaya mere n'okpuru nduzi nke bekee na "Arifon ghara."

Drug analogues "Indap", "Indiur", "Pamid", "Arindap," "Ionic", "Akripamid ghara" na ndị ọzọ.